Registration Assessment High-Risk Drugs MHRA BNF 28 August 2026 · 10 min read

High-Risk Medicines in UK Pharmacy: Monitoring, Toxicities, and MHRA Alerts

Complete clinical safety guide for Lithium, Methotrexate, Amiodarone, Digoxin, and Gentamicin. Target serum ranges, sampling times, and red flags.

1. High-Risk Drug Safety Matrix

High-risk medicines represent over 30% of clinical safety questions in the GPhC registration examination. Pharmacists must master therapeutic target ranges, sample timing post-dose, baseline safety checks, and critical MHRA safety alerts.

Medicine	Target Serum Therapeutic Level	Sample Timing Post-Dose	Critical Baseline & Routine Tests	Major Toxicity Symptoms
Lithium	0.4 - 1.0 mmol/L (0.8-1.0 for acute mania/relapse)	12 hours post-dose	Renal function (eGFR), Thyroid function (TFTs), Calcium, Weight.	Coarse tremor, ataxia, dysarthria, hyperreflexia, confusion.
Digoxin	0.8 - 2.0 mcg/L (1.0-2.6 nmol/L)	At least 6 hours post-dose	Serum potassium (hypokalaemia potentiation), renal function.	Nausea, vomiting, yellow-green visual halos (xanthopsia), heart block.
Theophylline	10 - 20 mg/L (55 - 110 micromol/L)	4 to 6 hours post oral dose	Hepatic enzymes, plasma potassium.	Tachycardia, arrhythmias, convulsions, severe vomiting.
Gentamicin	Trough: < 1.0 mg/L (< 2.0 for endocarditis)	Immediately prior to next dose	Serum creatinine, audiometry.	Ototoxicity (irreversible), nephrotoxicity (reversible).
Methotrexate	Standard oncology/rheumatology dosing	Weekly until stable, then monthly	FBC, LFTs, U&Es, Chest X-ray.	Sore throat/fever (bone marrow suppression), dry cough (pulmonary fibrosis).

2. Lithium Carbonate & Citrate: Essential Safety Protocols

Lithium has an extremely narrow therapeutic index. Toxicity can be precipitated by dehydration, sodium restriction, and interacting medications that decrease renal lithium clearance.

The "Triple Threat" Drug Interactions that Elevate Serum Lithium:

NSAIDs (e.g. Ibuprofen, Naproxen): Inhibit renal prostaglandin synthesis, reducing renal blood flow and increasing lithium reabsorption.
ACE Inhibitors / ARBs (e.g. Ramipril, Candesartan): Reduce glomerular filtration rate and promote sodium/lithium retention.
Thiazide & Loop Diuretics (e.g. Bendroflumethiazide, Furosemide): Induce natriuresis, triggering compensatory proximal tubular reabsorption of lithium ions.

Mandatory Patient Counselling Checklist:

Maintain consistent fluid intake (1.5 - 2.0 L/day) and avoid sudden dietary salt reduction.
Provide the official Lithium Treatment Pack (purple patient information booklet, record card, and alert card).
Brand-specific prescribing: Lithium preparations (Priadel, Camcolit, Liskonum) possess differing bioavailability; never switch brands without specialist supervision.

3. Oral Methotrexate: Preventing Once-Weekly Overdose Fatalities

Oral methotrexate for rheumatoid arthritis, psoriasis, and Crohn's disease must be taken ONCE WEEKLY on the same designated day. Accidental daily dosing can be fatal due to acute myelosuppression.

Statutory Safety Requirements:

Specific Day of the Week: The prescription and dispensing label must state the exact day of the week (e.g. *"Take 15 mg once weekly on MONDAYS"*), never *"as directed"*.
Only 2.5 mg Tablets Dispensed: To avoid confusion between 2.5 mg and 10 mg strengths, UK community pharmacies standardise on 2.5 mg tablets wherever possible.
Folic Acid Co-prescription: Prescribed (e.g. 5 mg once weekly, taken 24 to 48 hours after methotrexate) to minimise gastrointestinal and haematological side effects.

4. Amiodarone Hydrochloride: Multi-Organ Monitoring Requirements

Amiodarone contains iodine and has an exceptionally long terminal half-life (up to 50 days), causing cumulative tissue deposits across multiple organ systems.

Monitoring Schedule:

Baseline Tests: Thyroid Function Tests (TFTs), Liver Function Tests (LFTs), Serum Potassium, Baseline Chest X-ray, ECG (QTc interval).
Every 6 Months: TFTs, LFTs.
Clinical Toxicity Red Flags:
*Pulmonary Toxicity:* Progressive shortness of breath, dry cough, or unexplained fever.
*Ocular Toxicity:* Optic neuropathy/neuritis with blurred vision (requires urgent ophthalmology assessment).
*Dermatological:* Slate-grey skin discolouration and severe photosensitivity (advise SPF 50+ UVA/UVB protection).